| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |